The Immune Response to Ectromelia Virus in the Draining Lymph Node
引流淋巴结对湿疹病毒的免疫反应
基本信息
- 批准号:8891575
- 负责人:
- 金额:$ 60.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2014-11-30
- 项目状态:已结题
- 来源:
- 关键词:Animal VirusesAntigensAntiviral AgentsBloodBone MarrowCD4 Positive T LymphocytesCXCL9 geneCell Adhesion MoleculesCellsChimera organismDendritic CellsDistantEducational process of instructingEpithelialEventGenerationsGenesGoalsHealthHematogenousHematopoieticHumanHuman VirusITGAM geneITGAX geneImmigrationImmuneImmune responseImmunityImmunologyImmunophenotypingInfectionInfectious EctromeliaInflammatoryInflammatory ResponseInterferonsInvadedLeadLymphocyteMicroscopyModelingMouse Pox VirusMusMutant Strains MiceNatural Killer CellsOrganOrthopoxvirusPathway interactionsPeripheralPlayPopulationRecruitment ActivityResistanceRoleRouteSignal TransductionSiteSkinSmallpoxSmallpox VaccineSmallpox VirusesSurfaceSystemic infectionTextbooksTimeVaccine AdjuvantVaccinia virusVirusVirus DiseasesWorkautocrinechemokinecytokinedensityin vivolymph nodesmembermutantnovelnovel vaccinesparacrinepathogenresearch studyresponsesensortooltranscription factorvirology
项目摘要
DESCRIPTION (provided by applicant): To invade target organs, a large number of human and animal viruses, including members of the orthopoxvirus (OPV) genus, breach epithelial surfaces and then use a lympho-hematogenous (LH) route of dissemination through the regional lymph node (LN) and then the blood. OPVs include the cause of smallpox (variola virus; VARV), the smallpox vaccine (vaccinia virus; VACV), and the cause of mousepox (ectromelia virus; ECTV) that the main virology textbooks use as the archetype for LH dissemination. Immunology and virology textbooks also teach us that the primary function of LNs is to serve as sites of lymphocyte priming. However, work by us and others support the emerging concept that LNs also play an essential role in restricting the LH dissemination of pathogens. The major goal of this project is to understand the how this protective response is assembled in vivo. The Specific Aims are: Specific Aim 1. To determine the mechanism whereby CD11c+ CD11b+ inflammatory dendritic cells (iDC) are recruited to the D-LN and contribute to virus control. Specific Aim 2. To identify and characterize the TLR9/MyD88 expressing cells required for the induction of the early anti-ECTV response in the D-LN. Specific Aim 3. To investigate the mechanisms of cytolytic CD4+ T cell induction in the D-LN. With these three Aims we will discover novel mechanisms that permit the control in the D-LN of a virus that spreads lympho- hematogenously from the periphery. This should be applicable to many pathogenic viruses.
描述(由申请人提供):为入侵目标器官,包括正托病毒(OPV)属的大量人类和动物病毒,透明上皮表面,然后使用淋巴神经元(LH)通过区域淋巴结(LN)和血液进行淋巴神经病(LH)途径。 OPV包括天花(Variola病毒; VARV),天花疫苗(Vaccinia Virus; vacv)的原因,以及主要的病毒学教科书用作LHEDENSEMAINTIAN的主要病毒学教科书用作主要病毒学教科书的原因。免疫学和病毒学教科书还告诉我们,LNS的主要功能是充当淋巴细胞启动的部位。但是,我们和其他人的工作支持新兴的概念,即LNS在限制病原体的LH传播中也起着至关重要的作用。该项目的主要目标是了解如何在体内组装这种保护性响应。具体目的是:特定目标1。确定CD11C+ CD11b+炎症树突状细胞(IDC)的机制,并募集到D-LN并有助于病毒控制。具体目标2。识别和表征D-LN早期抗ECTV响应所需的TLR9/MYD88表达细胞。具体目的3。研究D-LN中细胞溶解CD4+ T细胞诱导的机理。通过这三个目标,我们将发现新的机制,这些机制允许在病毒的D-LN中控制,该病毒从周围传播淋巴肿瘤。这应该适用于许多病毒病毒。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Luis J Sigal其他文献
Luis J Sigal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Luis J Sigal', 18)}}的其他基金
Mechanisms of protective memory CD8 T-cell induction by mRNA-LNP vaccines
mRNA-LNP 疫苗诱导保护性记忆 CD8 T 细胞的机制
- 批准号:
10753981 - 财政年份:2023
- 资助金额:
$ 60.59万 - 项目类别:
Discovering new genes involved in monocyte-mediated protective anti-viral innate immunity through the generation of mice with targeted mutations
通过产生具有靶向突变的小鼠,发现参与单核细胞介导的保护性抗病毒先天免疫的新基因
- 批准号:
10303725 - 财政年份:2021
- 资助金额:
$ 60.59万 - 项目类别:
Discovering new genes involved in monocyte-mediated protective anti-viral innate immunity through the generation of mice with targeted mutations
通过产生具有靶向突变的小鼠,发现参与单核细胞介导的保护性抗病毒先天免疫的新基因
- 批准号:
10416067 - 财政年份:2021
- 资助金额:
$ 60.59万 - 项目类别:
Discovering new genes involved in protective T-cell responses through the generation of mice with targeted mutations
通过培育具有靶向突变的小鼠,发现参与保护性 T 细胞反应的新基因
- 批准号:
10042745 - 财政年份:2020
- 资助金额:
$ 60.59万 - 项目类别:
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
- 批准号:
8072956 - 财政年份:2010
- 资助金额:
$ 60.59万 - 项目类别:
Immune Mechanisms That Control Ectromelia Virus Infection
控制Ectromelia病毒感染的免疫机制
- 批准号:
7680613 - 财政年份:2009
- 资助金额:
$ 60.59万 - 项目类别:
相似国自然基金
钩吻素子对胃癌MHC-I类抗原呈递激活免疫应答的调控及其机制研究
- 批准号:82373138
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
嵌合抗原受体巨噬细胞(CAR-M)微马达的制备及其血管蜂窝网络磁驱行为机理与控制方法研究
- 批准号:52375565
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
KIF17介导肿瘤细胞MHC-II胞膜定位促进乳腺癌抗原提呈及免疫应答的机制研究
- 批准号:82372781
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
微量肝癌组织肿瘤新抗原高效稳定深度覆盖鉴定技术研究
- 批准号:32371503
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
肿瘤相关糖类抗原Tn促结直肠癌发生和转移的分子机制及干预研究
- 批准号:82372989
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
相似海外基金
Defining astrovirus-specific T cell responses
定义星状病毒特异性 T 细胞反应
- 批准号:
10667003 - 财政年份:2023
- 资助金额:
$ 60.59万 - 项目类别:
Pandemic Preparedness: Biocontainment Facility Upgrade and Integration at UTMB/Galveston National Laboratory
流行病防范:UTMB/加尔维斯顿国家实验室的生物防护设施升级和集成
- 批准号:
10611097 - 财政年份:2022
- 资助金额:
$ 60.59万 - 项目类别:
Immune correlates of protection against hepacivirus persistence.
抵抗肝炎病毒持久性的免疫相关性。
- 批准号:
10594475 - 财政年份:2021
- 资助金额:
$ 60.59万 - 项目类别:
Development of a host-targeted antiviral as a chronic hepatitis B therapeutic with potential to achieve a functional cure
开发一种针对宿主的抗病毒药物作为慢性乙型肝炎治疗剂,有可能实现功能性治愈
- 批准号:
10324480 - 财政年份:2021
- 资助金额:
$ 60.59万 - 项目类别:
Immune correlates of protection against hepacivirus persistence.
抵抗肝炎病毒持久性的免疫相关性。
- 批准号:
10378496 - 财政年份:2021
- 资助金额:
$ 60.59万 - 项目类别: